Axsome Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results on March 14, 2019

NEXT STORY
BeyondSpring Presents New Promising Data in Chemotherapy-Induced Neutropenia at 2019 ASCO-SITC Clinical Immuno-Oncology Symposium
PREV STORY
Novartis Cosentyx® shows superior improvements in psoriasis patients’ quality of life versus Janssen’s IL-23 Stelara®*
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

South and Central America Kidney Stones Retrieval Devices Market Forecast to 2027 – COVID-19 Impact and Regional Analysis by Type ; Treatment ; End User ; and Country

author_avatar
NASDAQ Market News

Apellis Reports Pegcetacoplan Demonstrates Greater Treatment Responses and Quality-of-Life Improvements Compared to C5 Inhibitors for PNH

author_avatar
NASDAQ Market News

New Data on Molecular Templates’ Engineered Toxin Bodies to be Presented at the American Association of Cancer Research (AACR) Virtual Annual Meeting II

author_avatar
NASDAQ Market News